C1q-calreticulin induced oxidative neurotoxicity: Relevance for the neuropathogenesis of Alzheimer's disease

Journal of Neuroimmunology

Volumn 135, Issue 1-2, 2003, Pages 62-71

  Luo, Xiaoguang ^a,b   Weber, Gregory A ^a   Zheng, Jialin ^a   Gendelman, Howard E ^a   Ikezu, Tsuneya ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

C1q; Calreticulin; Neurons; Reactive oxygen species; Amyloid peptide

Indexed keywords

CALRETICULIN; COMPLEMENT COMPONENT C1Q; IODINE 125; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; FEMALE; IMMUNOFLUORESCENCE; NERVE CELL; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 0037308834     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00444-7     Document Type: Article

References (53)

1. Atlante A., Calissano P., Bobba A., Giannattasio S., Marra E., Passarella S. Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Lett. 497:2001;1-5.
2. Chen S., Frederickson R.C., Brunden K.R. Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: complement activation and therapeutic approaches. Neurobiol. Aging. 17:1996;781-787.
3. Cho J.H., Homma K., Kanegasaki S., Natori S. Activation of human neutrophils by a synthetic anti-microbial peptide, KLKLLLLLKLK-NH2, via cell surface calreticulin. Eur. J. Biochem. 266:1999;878-885.
4. Cho J.H., Homma K.J., Kanegasaki S., Natori S. Activation of human monocyte cell line U937 via cell surface calreticulin. Cell Stress Chaperones. 6:2001;148-152.
5. Cunningham T.J., Hodge L., Speicher D., Reim D., Tyler-Polsz C., Levitt P., Eagleson K., Kennedy S., Wang Y. Identification of a survival-promoting peptide in medium conditioned by oxidatively stressed cell lines of nervous system origin. J. Neurosci. 18:1998;7047-7060.
6. Cunningham T.J., Jing H., Wang Y., Hodge L. Calreticulin binding and other biological activities of survival peptide Y-P30 including effects of systemic treatment of rats. Exp. Neurol. 163:2000;457-468.
7. Eggleton P., Lieu T.S., Zappi E.G., Sastry K., Coburn J., Zaner K.S., Sontheimer R.D., Capra J.D., Ghebrehiwet B., Tauber A.I. Calreticulin is released from activated neutrophils and binds to C1q and mannan-binding protein. Clin. Immunol. Immunopathol. 72:1994;405-409.
8. Eggleton P., Reid K.B., Tenner A.J. C1q - how many functions? How many receptors? Trends Cell Biol. 8:1998;428-431.
9. Feng X., Tonnesen M.G., Peerschke E.I., Ghebrehiwet B. Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell adhesion and spreading. J. Immunol. 168:2002;2441-2448.
10. Goicoechea S., Orr A.W., Pallero M.A., Eggleton P., Murphy-Ullrich J.E. Thrombospondin mediates focal adhesion disassembly through interactions with cell surface calreticulin. J. Biol. Chem. 275:2000;36358-36368.
11. Goodman E.B., Tenner A.J. Signal transduction mechanisms of C1q-mediated superoxide production. Evidence for the involvement of temporally distinct staurosporine-insensitive and sensitive pathways. J. Immunol. 148:1992;3920-3928.
12. Goodman E.B., Anderson D.C., Tenner A.J. C1q triggers neutrophil superoxide production by a unique CD18-dependent mechanism. J. Leukoc. Biol. 58:1995;168-176.
13. Gray A.J., Park P.W., Broekelmann T.J., Laurent G.J., Reeves J.T., Stenmark K.R., Mecham R.P. The mitogenic effects of the B beta chain of fibrinogen are mediated through cell surface calreticulin. J. Biol. Chem. 270:1995;26602-26606.
14. Guan E., Robinson S.L., Goodman E.B., Tenner A.J. Cell-surface protein identified on phagocytic cells modulates the C1q-mediated enhancement of phagocytosis. J. Immunol. 152:1994;4005-4016.
15. Jiang H., Burdick D., Glabe C.G., Cotman C.W., Tenner A.J. Beta-amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J. Immunol. 152:1994;5050-5059.
16. Johnson R.J., Xiao G., Shanmugaratnam J., Fine R.E. Calreticulin functions as a molecular chaperone for the beta-amyloid precursor protein. Neurobiol. Aging. 22:2001;387-395.
17. Kawashima T., Zappi E.G., Lieu T.S., Sontheimer R.D. Impact of ultraviolet radiation on the cellular expression of Ro/SS-A-autoantigenic polypeptides. Dermatology. 189:1994;6-10.
18. Klein A.M., Kowall N.W., Ferrante R.J. Neurotoxicity and oxidative damage of beta amyloid 1-42 versus beta amyloid 1-40 in the mouse cerebral cortex. Ann. N. Y. Acad. Sci. 893:1999;314-320.
19. Kwon M.S., Park C.S., Choi K., Ahnn J., Kim J.I., Eom S.H., Kaufman S.J., Song W.K. Calreticulin couples calcium release and calcium influx in integrin-mediated calcium signaling. Mol. Biol. Cell. 11:2000;1433-1443.
20. Lewen A., Sugawara T., Gasche Y., Fujimura M., Chan P.H. Oxidative cellular damage and the reduction of APE/Ref-1 expression after experimental traumatic brain injury. Neurobiol. Dis. 8:2001;380-390.
21. Lue L.F., Rydel R., Brigham E.F., Yang L.B., Hampel H., Murphy G.M. Jr., Brachova L., Yan S.D., Walker D.G., Shen Y., Rogers J. Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia. 35:2001;72-79.
22. Malhotra R., Willis A.C., Jensenius J.C., Jackson J., Sim R.B. Structure and homology of human C1q receptor (collectin receptor). Immunology. 78:1993;341-348.
23. Matsuoka Y., Picciano M., Malester B., LaFrancois J., Zehr C., Daeschner J.M., Olschowka J.A., Fonseca M.I., O'Banion M.K., Tenner A.J., Lemere C.A., Duff K. Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease. Am. J. Pathol. 158:2001;1345-1354.
24. McDonnell J.M., Jones G.E., White T.K., Tanzer M.L. Calreticulin binding affinity for glycosylated laminin. J. Biol. Chem. 271:1996;7891-7894.
25. McGrath L.T., McGleenon B.M., Brennan S., McColl D., Mc I.S., Passmore A.P. Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde. QJM. 94:2001;485-490.
26. Michalak M., Mariani P., Opas M. Calreticulin, a multifunctional Ca2+ binding chaperone of the endoplasmic reticulum. Biochem. Cell. Biol. 76:1998;779-785.
27. Noh K.M., Koh J.Y. Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes. J. Neurosci. 20:2000;RC111.
28. Nori A., Villa A., Podini P., Witcher D.R., Volpe P. Intracellular Ca2+ stores of rat cerebellum: heterogeneity within and distinction from endoplasmic reticulum. Biochem. J. 291:1993;199-204.
29. Ruiz S., Henschen-Edman A.H., Tenner A.J. Localization of the site on the complement component C1q required for the stimulation of neutrophil superoxide production. J. Biol. Chem. 270:1995;30627-30634.
30. Ruiz S., Henschen-Edman A.H., Nagase H., Tenner A.J. Digestion of C1q collagen-like domain with MMPs-1, -2, -3, and -9 further defines the sequence involved in the stimulation of neutrophil superoxide production. J. Leukoc. Biol. 66:1999;416-422.
31. Satoh T., Numakawa T., Abiru Y., Yamagata T., Ishikawa Y., Enokido Y., Hatanaka H. Production of reactive oxygen species and release of L-glutamate during superoxide anion-induced cell death of cerebellar granule neurons. J. Neurochem. 70:1998;316-324.
32. Seddiki N., Nato F., Lafaye P., Amoura Z., Piette J.C., Mazie J.C. Calreticulin, a potential cell surface receptor involved in cell penetration of anti-DNA antibodies. J. Immunol. 166:2001;6423-6429.
33. Shearman M.S., Hawtin S.R., Tailor V.J. The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides. J. Neurochem. 65:1995;218-227.
34. Shibata N. Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Neuropathology. 21:2001;82-92.
35. Stuart G.R., Lynch N.J., Lu J., Geick A., Moffatt B.E., Sim R.B., Schwaeble W.J. Localisation of the C1q binding site within C1q receptor/calreticulin. FEBS Lett. 397:1996;245-249.
36. Tacnet-Delorme P., Chevallier S., Arlaud G.J. Beta-amyloid fibrils activate the C1 complex of complement under physiological conditions: evidence for a binding site for A beta on the C1q globular regions. J. Immunol. 167:2001;6374-6381.
37. Taguchi J., Fujii A., Fujino Y., Tsujioka Y., Takahashi M., Tsuboi Y., Wada I., Yamada T. Different expression of calreticulin and immunoglobulin binding protein in Alzheimer's disease brain. Acta Neuropathol. (Berl.). 100:2000;153-160.
38. Tammariello S.P., Quinn M.T., Estus S. NADPH oxidase contributes directly to oxidative stress and apoptosis in nerve growth factor-deprived sympathetic neurons. J. Neurosci. 20:2000;RC53.
39. Tenner A.J. Functional aspects of the C1q receptors. Behring Inst. 1993;241-253.
40. Terai K., Walker D.G., McGeer E.G., McGeer P.L. Neurons express proteins of the classical complement pathway in Alzheimer disease. Brain Res. 769:1997;385-390.
41. Thiel S., Vorup-Jensen T., Stover C.M., Schwaeble W., Laursen S.B., Poulsen K., Willis A.C., Eggleton P., Hansen S., Holmskov U., Reid K.B., Jensenius J.C. A second serine protease associated with mannan-binding lectin that activates complement. Nature. 386:1997;506-510.
42. Tooyama I., Sato H., Yasuhara O., Kimura H., Konishi Y., Shen Y., Walker D.G., Beach T.G., Sue L.I., Rogers J. Correlation of the expression level of C1q mRNA and the number of C1q-positive plaques in the Alzheimer Disease temporal cortex. Analysis of C1q mRNA and its protein using adjacent or nearby sections. Dement. Geriatr. Cogn. Disord. 12:2001;237-242.
43. Valyi-Nagy T., Olson S.J., Valyi-Nagy K., Montine T.J., Dermody T.S. Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons. Virology. 278:2000;309-321.
44. van den Berg R.H., Faber-Krol M.C., Sim R.B., Daha M.R. The first subcomponent of complement, C1q, triggers the production of IL-8, IL-6, and monocyte chemoattractant peptide-1 by human umbilical vein endothelial cells. J. Immunol. 161:1998;6924-6930.
45. van den Berg R.H., Siegert C.E., Faber-Krol M.C., Huizinga T.W., van Es L.A., Daha M.R. Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 111:1998;359-364.
46. Velazquez P., Cribbs D.H., Poulos T.L., Tenner A.J. Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimer's disease pathogenesis. Nat. Med. 3:1997;77-79.
47. Webster S., Bonnell B., Rogers J. Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide. Am. J. Pathol. 150:1997;1531-1536.
48. Webster S.D., Yang A.J., Margol L., Garzon-Rodriguez W., Glabe C.G., Tenner A.J. Complement component C1q modulates the phagocytosis of Abeta by microglia. Exp. Neurol. 161:2000;127-138.
49. White T.K., Zhu Q., Tanzer M.L. Cell surface calreticulin is a putative mannoside lectin which triggers mouse melanoma cell spreading. J. Biol. Chem. 270:1995;15926-15929.
50. Xiao G., Chung T.F., Fine R.E., Johnson R.J. Calreticulin is transported to the surface of NG108-15 cells where it forms surface patches and is partially degraded in an acidic compartment. J. Neurosci. Res. 58:1999;652-662.
51. Xiao G., Chung T.F., Pyun H.Y., Fine R.E., Johnson R.J. KDEL proteins are found on the surface of NG108-15 cells. Brain Res. Mol. Brain Res. 72:1999;121-128.
52. Yasojima K., Schwab C., McGeer E.G., McGeer P.L. Up-regulated production and activation of the complement system in Alzheimer's disease brain. Am. J. Pathol. 154:1999;927-936.
53. Zheng J., Thylin M.R., Ghorpade A., Xiong H., Persidsky Y., Cotter R., Niemann D., Che M., Zeng Y.C., Gelbard H.A., Shepard R.B., Swartz J.M., Gendelman H.E. Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J. Neuroimmunol. 98:1999;185-200.